BSX Boston Scientific Earnings and EPS analysis

  1. Stocks
  2. Healthcare
  3. NYSE: BSX
  4. Earnings
Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 83

EPS in 2026 (TTM): $2.38

Last Report Period Date: Sep 30, 2026

Currently, BSX's 12-month EPS stands at $2.38, according to the most recent financial reports. Boston Scientific's earnings per share in 2025 was reported at $1.96, marking a rise from $1.26 in 2024. BSX recorded an EPS of $0.4 for the quarterly period ending on Sep 30, 2026.

BSX earnings history

Historical annual and quarterly earnings per share (EPS) data for Boston Scientific
EPS (TTM)
$2.38
EPS Growth YoY (Quarterly)
-21.6%
EPS (Quarterly)
$0.4
EPS Growth (Quarterly)
-35.5%

In 2025, Boston Scientific's earnings per share was $1.96, a rise of 55.6% from $1.26 in 2024. The quarterly earnings per share for the period ending Sep 30, 2026, was $0.4, showing a 21.6% decline compared to the same quarter last year. The trailing twelve months EPS for BSX is $2.38 as of September 2026. Boston Scientific's full-year EPS for 2024 was $1.26, a 16.7% rise compared to the previous year.

BSX EPS vs price chart

BSX EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-21.6%
EPS growth YoY
55.6%
EPS growth 3Y avg
63.3%
EPS growth 5Y avg
N/A

Over the past 12 months, Boston Scientific has recorded an earnings per share growth rate of -21.6% (YoY, quarterly). Over an extended period, the company recorded an average EPS annual growth rate of 63.3% per year for the last 3 years.

BSX Earnings Waterfall

Breakdown of revenue, profit and net income for Boston Scientific

BSX Earnings vs Peers

What are the earnings of BSX compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
TFX Teleflex Incorporated 18.48 -1,462.4% N/A N/A
BSX Boston Scientific Corp 18.59 55.6% 63.3% N/A
CNMD CONMED Corp 20.8 -64.6% N/A 35.7%
MDT Medtronic Plc 24.78 3.3% 9.8% 6.9%
MMSI Merit Medical Systems Inc 32.23 4.8% 18.3% N/A
SYK Stryker Corp 33.11 8% 10.9% 14.8%
EW Edwards Lifesciences Corp 59.6 -73.6% -9.2% 6.9%
ANGO Angiodynamics Inc N/A -6% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.